SCHEMBL2619280

SCHEMBL2619280

Bc1ccc2cc[nH]c(=O)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.53
CHEK1 O14757 1/20 0.47
ATIC P31939 1/20 0.40
GRM5 P41594 1/20 0.40
ROCK2 O75116 7/20 0.40
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
BLM P54132 1/20 0.36
PARP15 Q460N3 1/20 0.36
HSD17B10 Q99714 1/20 0.36
RECQL P46063 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPK14 Q16539 1/20 0.36
ROCK1 Q13464 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6005220 0.84 PARP1 (0.53) PARP1CHEK1GRM5ROCK2ROCK1
SCHEMBL31352392 0.76 CHEK1 (0.77) PARP1CHEK1ROCK2ALDH1A1
SCHEMBL1536413 0.76 PARP1 (0.53) PARP1CHEK1MAPK14ROCK1PRKACA
SCHEMBL31038353 0.76 PARP1 (0.53) PARP1CHEK1ATICGRM5ROCK2
SCHEMBL1038250 0.76 PARP1 (0.53) PARP1CHEK1ATICGRM5ROCK2
SCHEMBL1868599 0.76 AHR (0.53) PARP1CHEK1MAPK14ROCK1PRKACA
SCHEMBL3004117 0.76 PARP1 (0.53) PARP1CHEK1ATICGRM5ROCK2
SCHEMBL1536457 0.76 CHEK1 (0.77) PARP1CHEK1ROCK2ALDH1A1
SCHEMBL29379996 0.76 PARP1 (0.53) PARP1CHEK1ATICGRM5ROCK2
SCHEMBL30349914 0.76 PARP1 (0.53) PARP1CHEK1ATICGRM5ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120094997-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094997-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC1, HDAC5 PARP1 383/4885CHEK1 2998/4885ATIC 4052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.